UCB Share Price Other OTC
Stocks
UCBJF
BE0003739530
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.64TCr 5.3TCr 4.31TCr 3.96TCr 7.46TCr 5,11300Cr 7.57TCr 51TCr 20TCr 2,50200Cr 20TCr 19TCr 8,64300Cr | P/E 2026 * |
26.1x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.62TCr 5.27TCr 4.29TCr 3.94TCr 7.42TCr 5,08700Cr 7.53TCr 51TCr 20TCr 2,48900Cr 20TCr 19TCr 8,59800Cr | EV / Sales 2026 * |
5.41x | EV / Sales 2027 * | 4.57x |
| Free-Float |
61.59% | Yield 2026 * |
0.6% | Yield 2027 * | 0.62% |
Last Transcript: UCB
| 1 day | -0.39% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | -.--% | - | - | 5.3TCr | |
| -3.19% | -1.72% | +16.42% | -10.19% | 6.87TCr | |
| -1.65% | +37.20% | +37.20% | +37.20% | 4.36TCr | |
| -2.83% | -4.08% | -53.81% | -55.84% | 4.07TCr | |
| -1.40% | +1.66% | +56.83% | -27.61% | 3TCr | |
| -1.72% | -14.09% | +79.22% | -52.31% | 2.37TCr | |
| -0.38% | +1.32% | +69.24% | +83.75% | 2.35TCr | |
| +0.11% | +2.44% | +4.06% | +181.25% | 2.05TCr | |
| -0.39% | +1.58% | +71.18% | +126.61% | 1.67TCr | |
| -0.27% | -0.57% | +79.57% | +147.26% | 1.62TCr | |
| Average | -1.20% | -0.09% | +39.99% | +47.79% | 3.15TCr | |
| Weighted average by Cap. | -1.57% | +0.35% | +29.34% | +23.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 854.34Cr 975.05Cr 793.13Cr 728.81Cr 1.37TCr 94TCr 1.39TCr 9.45TCr 3.7TCr 46TCr 3.66TCr 3.58TCr 1,59000Cr | 964.37Cr 1.1TCr 895.27Cr 822.68Cr 1.55TCr 1,06200Cr 1.57TCr 11TCr 4.17TCr 52TCr 4.13TCr 4.04TCr 1,79500Cr |
| Net income | 177.01Cr 202.01Cr 164.32Cr 151Cr 284.53Cr 19TCr 288.72Cr 1.96TCr 766.18Cr 9.54TCr 758.34Cr 742Cr 33TCr | 227.71Cr 259.89Cr 211.4Cr 194.26Cr 366.04Cr 25TCr 371.43Cr 2.52TCr 985.67Cr 12TCr 975.59Cr 954.56Cr 42TCr |
| Net Debt | -24Cr -28Cr -22Cr -21Cr -39Cr -2.67TCr -40Cr -267.87Cr -104.84Cr -1.31TCr -103.77Cr -101.53Cr -4.51TCr | -232.32Cr -265.15Cr -215.68Cr -198.19Cr -373.45Cr -26TCr -378.95Cr -2.57TCr -1.01TCr -13TCr -995.34Cr -973.89Cr -43TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
